Partial growth hormone deficiency in adults; should we be looking for it?
AuthorsShalet, Stephen M
AffiliationDepartment of Endocrinology, Christie Hospital NHS Trust, Manchester M20 4BX, UK.
MetadataShow full item record
AbstractSummary Quantitatively GH secretion exists as a continuum in states ranging from good health through to hypopituitarism. Currently GH replacement is considered only for adults designated as being severely GH deficient (GHD). In clinical practice the gold standard, on which the biochemical diagnosis of severe GHD is based, centres on the presence of two or more additional anterior pituitary hormone deficits. Cohorts of adults with partial GHD (GHI) have been reported with adverse body composition changes, dyslipidaemia, insulin resistance, altered cardiac performance and increased carotid intima-media thickness. The diagnosis of GHI in an individual patient, however, is extremely difficult because such patients rarely exhibit additional anterior pituitary hormone deficits and the levels of GH-dependent proteins, including IGF-I, are normal in the majority. Currently GH replacement therapy should only be considered in a patient characterised as GHI by dynamic GH testing in whom there is a plausible cause for hypopituitarism and in whom the IGF-I level is pathologically low.
CitationPartial growth hormone deficiency in adults; should we be looking for it? 2010: Clin Endocrinol
- Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
- Authors: Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F
- Issue date: 2005 Jun
- The diagnosis of partial growth hormone deficiency in adults with a putative insult to the hypothalamo-pituitary axis.
- Authors: Murray RD, Bidlingmaier M, Strasburger CJ, Shalet SM
- Issue date: 2007 May
- The phenotype of adults with partial growth hormone deficiency.
- Authors: Murray RD
- Issue date: 2005
- Adults with partial growth hormone deficiency have an adverse body composition.
- Authors: Murray RD, Adams JE, Shalet SM
- Issue date: 2004 Apr
- Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
- Authors: Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S
- Issue date: 1998 May